Junshi Biosciences is a leading pharmaceutical company operating in discovering and developing monoclonal antibody drugs in China. Founder Jun Xiong has strong spirit of innovation; core team has established the leading position in the field of tumor immunity research and development.
The Company has produced a robust pipeline of monoclonal antibody drugs which cover tumor, cardiovascular disease, osteoporosis, and many other fields.
Member count: 1001-5000
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Loyal Vall... | loyalvalle... |
Mentions in press and media 26
| Date | Title | Description | Category | Author | Source |
| 14.01.2022 | Coherus Bi... | Coherus and Junshi Biosciences... | - | - | marketscre... |
| 10.01.2022 | Coherus an... | • Coherus and Junshi Bioscienc... | - | - | marketscre... |
| 05.01.2022 | Junshi Bio... | SHANGHAI, China and SINGAPORE,... | - | - | marketscre... |
| 13.12.2021 | Junshi Bio... | SHANGHAI, China and REDWOOD CI... | - | - | marketscre... |
| 30.11.2021 | Junshi Bio... | SHANGHAI, China, Nov. 30, 2021... | - | - | marketscre... |
| 15.11.2021 | Coherus an... | REDWOOD CITY, Calif. and SHANG... | - | - | marketscre... |
| 15.11.2021 | Junshi Bio... | SHANGHAI, China and REDWOOD CI... | - | - | marketscre... |
| 01.11.2021 | Junshi Bio... | FDA has granted the toripalima... | - | - | marketscre... |
| 01.11.2021 | Coherus an... | FDA has granted the toripalima... | - | - | marketscre... |
| 15.09.2021 | Shanghai J... | SHANGHAI and REDWOOD CITY, Cal... | - | - | marketscre... |
Show more